A phase II, multicentre, open label, prospective, interventional study to evaluate the sperm DNA fragmentation in idiopathic male infertility before and after treatment with Gonal-f PEN 900 IU.

Trial Profile

A phase II, multicentre, open label, prospective, interventional study to evaluate the sperm DNA fragmentation in idiopathic male infertility before and after treatment with Gonal-f PEN 900 IU.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Dec 2012

At a glance

  • Drugs Follitropin alfa (Primary)
  • Indications Asthenozoospermia; Azoospermia; Teratospermia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 27 Dec 2012 Actual initiation date 14 Apr 2011 added as reported by EudraCT.
    • 22 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top